HIV Vaccine Vector-Host Interactions: Understanding the Biology and Immunology (R01)

Archived

National Institutes of Health

Description

The purpose of this Funding Opportunity Announcement (FOA) is to support increased understanding of the biology and immunology of natural viral infections and HIV vaccine vectors. Applications should focus on four vaccine viral vector platforms developed from Adenoviridae, Poxviridae, Herpesviridae, or Adeno-associated viruses in humans or non-human primates (NHPs). Goals of the research include the development of improved safety models to assess the potential vaccine-related effects such as increased HIV infection rates due to immune activated vector-specific HIV target cells (e.g. CD4+ T-cells).

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Independent school districts
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Public housing authorities / Indian housing authorities
  • Native American tribal organizations (other than Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedMay 12, 2014
  • ClosesJan 7, 2017
  • CFDA93.855, 93.856
Categories

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro